Identifying Oxidized Lipid Metabolism-Related LncRNAs As Prognostic Biomarkers of Head and Neck Squamous Cell Carcinoma

Overview

Journal J Pers Med

Date 2023 Mar 29

PMID 36983670

Authors

Ziwei Zhang

Byeong Seop Kim

Wenqing Han

Xiaojun Chen

Yingjie Yan

Li Lin

Gang Chai

Affiliations

Soon will be listed here.

Abstract

The relationship between oxidized lipid metabolism and the immunological function of cancer is well known. However, the functions and regulatory mechanisms of lncRNAs associated with oxidized lipid metabolism in head and neck squamous cell carcinoma (HNSCC) remain to be fully elucidated. In this study, we established an oxidized lipid metabolism-related lncRNA prognostic signature to assess the prognosis and immune infiltration of HNSCC patients. The HNSCC transcriptome was obtained from The Cancer Genome Atlas. The choice of the target genes with a relevance score greater than 10 was performed via a correlation analysis by GeneCards. Patients were categorized by risk score and generated with multivariate Cox regression, which was then validated and evaluated using the Kaplan-Meier analysis and time-dependent receiver operating characteristics (ROC). A nomogram was constructed by combining the risk score with the clinical data. We constructed a risk score with 24 oxidized lipid metabolism-related lncRNAs. The areas' 1-, 2-, and 3-year OS under the ROC curve (AUC) were 0.765, 0.724, and 0.724, respectively. Furthermore, the nomogram clearly distinguished the survival probabilities of patients in high- and low-risk groups, between which substantial variations were revealed by immune infiltration analysis. The results supported the fact that oxidized lipid metabolism-related lncRNAs might predict prognoses and assist with differentiating amid differences in immune infiltration in HNSCC.

Citing Articles

Comprehensive network pharmacology and experimental study to investigate the effect and mechanism of solasonine on breast carcinoma treatment.

Ge W, Gao M, Dai Y, Zheng G, Yang L, Zuo W Cancer Cell Int. 2025; 25(1):49.

PMID: 39962568 PMC: 11834262. DOI: 10.1186/s12935-025-03665-6.

Integrated Network Pharmacology, Machine Learning and Experimental Validation to Identify the Key Targets and Compounds of for the Treatment of Breast Cancer.

Ying H, Kong W, Xu X Onco Targets Ther. 2025; 18():49-71.

PMID: 39835272 PMC: 11745062. DOI: 10.2147/OTT.S486300.

References

Sutaria S, Gori S, Morris J, Xie Z, Fu X, Nantz M . Lipid Peroxidation Produces a Diverse Mixture of Saturated and Unsaturated Aldehydes in Exhaled Breath That Can Serve as Biomarkers of Lung Cancer-A Review. Metabolites. 2022; 12(6). PMC: 9229171. DOI: 10.3390/metabo12060561. View

Tomita K, Takashi Y, Ouchi Y, Kuwahara Y, Igarashi K, Nagasawa T . Lipid peroxidation increases hydrogen peroxide permeability leading to cell death in cancer cell lines that lack mtDNA. Cancer Sci. 2019; 110(9):2856-2866. PMC: 6726706. DOI: 10.1111/cas.14132. View

Valko M, Rhodes C, Moncol J, Izakovic M, Mazur M . Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006; 160(1):1-40. DOI: 10.1016/j.cbi.2005.12.009. View

Zhong H, Yin H . Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria. Redox Biol. 2015; 4:193-9. PMC: 4803793. DOI: 10.1016/j.redox.2014.12.011. View

Ulker O, Panieri E, Suzen S, Jaganjac M, Zarkovic N, Saso L . Short overview on the relevance of microRNA-reactive oxygen species (ROS) interactions and lipid peroxidation for modulation of oxidative stress-mediated signalling pathways in cancer treatment. J Pharm Pharmacol. 2021; 74(4):503-515. DOI: 10.1093/jpp/rgab045. View

Zhao Z, Zheng R, Wang X, Li T, Dong X, Zhao C . Integrating Lipidomics and Transcriptomics Reveals the Crosstalk Between Oxidative Stress and Neuroinflammation in Central Nervous System Demyelination. Front Aging Neurosci. 2022; 14:870957. PMC: 9083465. DOI: 10.3389/fnagi.2022.870957. View

Marur S, Forastiere A . Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clin Proc. 2016; 91(3):386-96. DOI: 10.1016/j.mayocp.2015.12.017. View

Xiong Y, Si Y, Feng Y, Zhuo S, Cui B, Zhang Z . Prognostic value of lipid metabolism-related genes in head and neck squamous cell carcinoma. Immun Inflamm Dis. 2020; 9(1):196-209. PMC: 7860527. DOI: 10.1002/iid3.379. View

Christensen L, True K, Hamilton M, Nielsen M, Damas N, Damgaard C . SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism. Mol Oncol. 2016; 10(8):1266-82. PMC: 5423192. DOI: 10.1016/j.molonc.2016.06.003. View

10.

Shen L, Li N, Zhou Q, Li Z, Shen L . Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma. Front Oncol. 2021; 11:743611. PMC: 8517509. DOI: 10.3389/fonc.2021.743611. View

11.

Mitra R, Goodman Jr O . CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR. Prostate. 2015; 75(5):527-38. DOI: 10.1002/pros.22940. View

12.

Arroyo-Solera I, Pavon M, Leon X, Lopez M, Gallardo A, Cespedes M . Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma. Head Neck. 2018; 41(2):429-439. DOI: 10.1002/hed.25437. View

13.

Stalnecker C, Grover K, Edwards A, Coleman M, Yang R, DeLiberty J . Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors. Cancer Res. 2021; 82(4):586-598. PMC: 8886214. DOI: 10.1158/0008-5472.CAN-21-1443. View

14.

Sun Q, Li Y, Yang X, Wu X, Liu Z, Mou Y . Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma. Front Immunol. 2021; 12:782216. PMC: 8645855. DOI: 10.3389/fimmu.2021.782216. View

15.

Xu P, Xiao H, Yang Q, Hu R, Jiang L, Bi R . The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer. Exp Mol Med. 2020; 52(1):41-55. PMC: 7000404. DOI: 10.1038/s12276-019-0356-6. View

16.

Gottgens E, van den Heuvel C, de Jong M, Ham Kaanders J, Leenders W, Ansems M . ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker. Cancers (Basel). 2019; 11(12). PMC: 6966650. DOI: 10.3390/cancers11121971. View

17.

Yang K, Zhang S, Zhang D, Tao Q, Zhang T, Liu G . Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis. Int J Clin Oncol. 2019; 24(9):1030-1041. PMC: 6687676. DOI: 10.1007/s10147-019-01435-9. View

18.

Jiang Y, Guo H, Tong T, Xie F, Qin X, Wang X . lncRNA lnc-POP1-1 upregulated by VN1R5 promotes cisplatin resistance in head and neck squamous cell carcinoma through interaction with MCM5. Mol Ther. 2021; 30(1):448-467. PMC: 8753295. DOI: 10.1016/j.ymthe.2021.06.006. View

19.

Erejuwa O, Sulaiman S, Ab Wahab M . Evidence in support of potential applications of lipid peroxidation products in cancer treatment. Oxid Med Cell Longev. 2013; 2013:931251. PMC: 3867858. DOI: 10.1155/2013/931251. View

20.

Jaganjac M, Sunjic S, Zarkovic N . Utilizing Iron for Targeted Lipid Peroxidation as Anticancer Option of Integrative Biomedicine: A Short Review of Nanosystems Containing Iron. Antioxidants (Basel). 2020; 9(3). PMC: 7139573. DOI: 10.3390/antiox9030191. View